Espero Biopharma Competitors and Similar CompaniesClear all

Espero Biopharma's competitors and similar companies include UCB, Genentech, Vertex Pharmaceuticals and CSL Behring.

	Espero Biopharma Espero Biopharma (formerly known as Espero Pharmaceuticals) is a biopharmaceutical company focused on the development of drugs for cardiovascular treatments.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.	Vertex Pharmaceuticals Vertex Pharmaceuticals is a biotechnology company that focuses on discovering, developing, and producing medicines.	CSL Behring CSL Behring is a provider of life-saving medicines.
Founding Date	Founding Date 2011	Founding Date 1928	Founding Date 1976	Founding Date 1989	Founding Date 1904
Type	Type Private	Type Public	Type Subsidiary	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Wilmington, US HQ	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Portland, US South San Francisco, US South San Francisco, US South San Francisco, US see more	Locations Boston, US HQ St Leonards, AU Wien, AT Bruxelles, BE São Paulo, BR Toronto, CA Praha, CZ see more	Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more
Employees	Employees 5	Employees 9,052	Employees 18,077	Employees 5,40013% increase	Employees 7,5692% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 34.3 b	Valuation ($) N/A	Valuation ($) 121.4 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $12b (FY, 2025)	Revenue (est.) $7.9b (FY, 2020)
Cost of goods	Cost of goods N/A	Cost of goods €1.4b (FY, 2025)	Cost of goods N/A	Cost of goods $1.7b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit €7.2b (FY, 2025)	Gross profit N/A	Gross profit $10.4b (FY, 2025)	Gross profit $4.5b (FY, 2020)
Operating ⚠
Countries	Countries N/A	Countries 35 (FY, 2019)	Countries N/A	Countries N/A	Countries 100 (Dec, 2020)